HHS Secretary Leavitt Calls For “Explicit Extraterritorial Jurisdiction” For U.S. FDA
This article was originally published in PharmAsia News
Executive Summary
U.S. Health and Human Services Secretary Michael Leavitt requested Congress in a Feb. 22 letter to grant FDA "explicit extraterritorial jurisdiction" to investigate manufacturers whose products are subject to the Federal Food, Drug, and Cosmetic Act